Liver Visualization & Virtual Parenchyma Companies and Future Market Positioning

Liver Visualization & Virtual Parenchyma Market Top Vendors and Their Offerings

GE HealthCare

Headquarters: Illinois, U.S.
Liver Visualization & Virtual Parenchyma Platforms: Liver ASSIST virtual parenchyma

Siemens Healthineers

Headquarters: Erlangen, Germany
Liver Visualization & Virtual Parenchyma Platforms: syngo.via Frontier or syngo.CT Liver Analysis

Koninklijke Philips N.V.

Headquarters: Amsterdam, Netherlands
Liver Visualization & Virtual Parenchyma Platforms: IntelliSpace Portal

Fujifilm Holdings Corporation

Headquarters: Tokyo, Japan
Liver Visualization & Virtual Parenchyma Platforms: Synapse 3D

Canon Medical Systems

Headquarters: Otawara, Japan
Liver Visualization & Virtual Parenchyma Platforms: Vitrea Advanced Visualization

TeraRecon

Headquarters: North Carolina, U.S.
Liver Visualization & Virtual Parenchyma Platforms: TeraRecon AV

MeVis Medical Solutions AG

Headquarters: Bremen, Germany
Liver Visualization & Virtual Parenchyma Platforms: MeVis Distant Services or MeVis Liver Suite

Ziosoft

Headquarters: Tokyo, Japan
Liver Visualization & Virtual Parenchyma Platforms: Ziostation2

Ceevra, Inc.

Headquarters: California, U.S.
Liver Visualization & Virtual Parenchyma Platforms: Ceevra Reveal

Innersight Labs

Headquarters: London, UK
Liver Visualization & Virtual Parenchyma Platforms: Innersight3D

Market Value Chain Analysis

R&D

• The R&D of the liver visualization & virtual parenchyma focuses on the use of AI-driven automation.
• Key players: GE HealthCare, Canon Medical Systems.

Clinical Trials and Regulatory Approvals

• The procedural efficiency, clinical utility, and accuracy are evaluated in the clinical trials and regulatory approvals of the liver visualization & virtual parenchyma.
• Key players: MeVis Medical Solutions AG, GE HealthCare.

Patient Support and Services

• Visual reporting and multidisciplinary coordination are provided in the patient support and services of the liver visualization & virtual parenchyma.
• Key players: GE HealthCare, Max Healthcare.

Market Growth

The liver visualization & virtual parenchyma market is rapidly advancing on a  scale, with expectations of accumulating hundreds of millions in revenue between 2026 and 2035. Market forecasts suggest robust development fueled by increased investments, innovation, and rising demand across various industries.

What are the Recent Developments in the Market?

• In July 2025, to overcome the increasing liver diseases like Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), by enhancing the diagnostic accuracy and patient outcomes, a collaboration between Apollo Hospitals and Siemens Healthineers was announced, where they will develop non-invasive, advanced ultrasound imaging and AI-driven clinical solutions.
• In April 2025, a total of $1.25 million in funding was secured by Tvaster Genkalp, where the capital will be utilized to launch its Episcreen™ Liver, which is a non-invasive liver cancer detection test.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com